4.7 Article

Inhibition of Bruton Tyrosine Kinase Reduces Neuroimmune Cascade and Promotes Recovery after Spinal Cord Injury

Related references

Note: Only part of the references are listed.
Article Anatomy & Morphology

Ibrutinib reduces neutrophil infiltration ,preserves neural tissue and enhances locomotor recovery in mouse contusion model of spinal cord injury

Somayyeh Torabi et al.

Summary: The study found that administering Ibrutinib in the acute phase of SCI can decrease neutrophil infiltration, promote neural tissue protection, and enhance locomotor functional recovery. Ibrutinib treatment may be an effective immunotherapeutic intervention for traumatic SCI.

ANATOMY & CELL BIOLOGY (2021)

News Item Biotechnology & Applied Microbiology

BTK blockers make headway in multiple sclerosis

Elie Dolgin

NATURE BIOTECHNOLOGY (2021)

Review Biochemistry & Molecular Biology

Therapeutic Targeting of Autoreactive B Cells: Why, How, and When?

Zachary C. Stensland et al.

Summary: Targeted therapies focusing on autoantigen-specific B cells have shown potential for more precise treatment of autoimmune disorders, while also presenting challenges that need to be addressed for their clinical applicability.

BIOMEDICINES (2021)

Review Oncology

Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and Disease

Philipp von Hundelshausen et al.

Summary: Bruton tyrosine kinase (Btk) is expressed in B-lymphocytes, myeloid cells and platelets, and Btk-inhibitors (BTKi) are used to treat patients with B-cell malignancies, developed against autoimmune diseases, and proposed as novel antithrombotic drugs, and tested in patients with severe COVID-19. This review describes twelve BTKi, focusing on their pharmacological properties, targeted disease, bleeding side effects and actions on platelets to clarify mechanisms underlying bleeding. Specific platelet function tests in blood might help estimate the probability of bleeding of newly developed BTKi.

CANCERS (2021)

Review Cell Biology

Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects

H. Yesid Estupinan et al.

Summary: BTK inhibitors have shown efficacy in treating B-cell tumors, but are increasingly being tested for autoimmune diseases and inflammation. Adverse effects such as cardiovascular issues and bleeding can persist, while skin manifestations and diarrhea may occur early but subside.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Immunology

The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases

Tamsin Cargill et al.

Summary: B cells play a crucial role in immune mediated liver diseases by potentially initiating and maintaining the diseases through producing autoantibodies and activating T cells. Future research should focus on developing targeted B cell therapies.

FRONTIERS IN IMMUNOLOGY (2021)

Review Cell Biology

B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells

Carlo G. Bonasia et al.

Summary: This article discusses the key role of autoreactive B cells in autoimmune diseases, the use of novel techniques to identify these cells, and potential therapeutic strategies. The mechanisms underlying the development of autoreactive B cells are still not fully understood.

CELLS (2021)

Article Multidisciplinary Sciences

Innate Immune Functions of Astrocytes are Dependent Upon Tumor Necrosis Factor-Alpha

Kyla R. Rodgers et al.

SCIENTIFIC REPORTS (2020)

Article Immunology

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19

Mark Roschewski et al.

SCIENCE IMMUNOLOGY (2020)

Article Hematology

Platelet function and bleeding in chronic lymphocytic leukemia and mantle cell lymphoma patients on ibrutinib

Elena A. Dmitrieva et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Review Immunology

Astrocyte Reactivity: Subtypes, States, and Functions in CNS Innate Immunity

Michael V. Sofroniew

TRENDS IN IMMUNOLOGY (2020)

Article Critical Care Medicine

Repositioning Flubendazole for Spinal Cord Injury

Chen Guang Yu et al.

JOURNAL OF NEUROTRAUMA (2019)

Review Clinical Neurology

Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms

Arsalan Alizadeh et al.

FRONTIERS IN NEUROLOGY (2019)

Article Immunology

The Role of Bruton's Tyrosine Kinase in Immune Cell Signaling and Systemic Autoimmunity

Jasper Rip et al.

CRITICAL REVIEWS IN IMMUNOLOGY (2018)

Review Immunology

Targeting B Cells and Plasma Cells in Autoimmune Diseases

Katharina Hofmann et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Immunology

Elevated Autoantibodies in Subacute Human Spinal Cord Injury Are Naturally Occurring Antibodies

Angel Arevalo-Martin et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Critical Care Medicine

Characterization of the Antibody Response after Cervical Spinal Cord Injury

Antigona Ulndreaj et al.

JOURNAL OF NEUROTRAUMA (2017)

Article Multidisciplinary Sciences

Neurotoxic reactive astrocytes are induced by activated microglia

Shane A. Liddelow et al.

NATURE (2017)

Review Immunology

Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity

Alexander N. R. Weber et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Clinical Neurology

Systemic and Local Cytokine Profile following Spinal Cord Injury in Rats: A Multiplex Analysis

Yana O. Mukhamedshina et al.

FRONTIERS IN NEUROLOGY (2017)

Review Immunology

Altered B cell signalling in autoimmunity

David J. Rawlings et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Review Immunology

The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy

Leslie J. Crofford et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)

Review Cell Biology

Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord Injury

Elisa Garcia et al.

MEDIATORS OF INFLAMMATION (2016)

Review Immunology

Astrocytes: Key Regulators of Neuroinflammation

Emanuela Colombo et al.

TRENDS IN IMMUNOLOGY (2016)

Review Biochemistry & Molecular Biology

B cells responses and cytokine production are regulated by their immune microenvironment

Monica I. Vazquez et al.

CYTOKINE (2015)

Article Medicine, General & Internal

Traumatic Spinal Cord Injury in the United States, 1993-2012

Nitin B. Jain et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Critical Care Medicine

Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum Biomarkers

Jacob Kjell et al.

JOURNAL OF NEUROTRAUMA (2015)

Review Clinical Neurology

Innate and adaptive immune responses in the CNS

Ari Waisman et al.

LANCET NEUROLOGY (2015)

Review Immunology

Control of autoimmune CNS inflammation by astrocytes

Veit Rothhammer et al.

SEMINARS IN IMMUNOPATHOLOGY (2015)

Review Clinical Neurology

Immune dysfunction and chronic inflammation following spinal cord injury

D. J. Allison et al.

SPINAL CORD (2015)

Review Pharmacology & Pharmacy

Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis

Jennifer A. Whang et al.

DRUG DISCOVERY TODAY (2014)

Review Neurosciences

Lymphocytes and autoimmunity after spinal cord injury

T. Bucky Jones

EXPERIMENTAL NEUROLOGY (2014)

Review Critical Care Medicine

Modulating Inflammatory Cell Responses to Spinal Cord Injury: All in Good Time

Amy L. Bowes et al.

JOURNAL OF NEUROTRAUMA (2014)

Article Multidisciplinary Sciences

Btk Regulates Macrophage Polarization in Response to Lipopolysaccharide

Joan Ni Gabhann et al.

PLOS ONE (2014)

Article Critical Care Medicine

Calpain 1 Knockdown Improves Tissue Sparing and Functional Outcomes after Spinal Cord Injury in Rats

Chen Guang Yu et al.

JOURNAL OF NEUROTRAUMA (2013)

Article Oncology

Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)

Jan A. Burger et al.

LEUKEMIA & LYMPHOMA (2013)

Review Medicine, Research & Experimental

Innate immunity in the central nervous system

Richard M. Ransohoff et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Review Biology

B Cells in Autoimmune Diseases

Christiane S. Hampe

SCIENTIFICA (2012)

Review Clinical Neurology

Emerging Concepts in Myeloid Cell Biology after Spinal Cord Injury

Alicia L. Hawthorne et al.

NEUROTHERAPEUTICS (2011)

Article Critical Care Medicine

Acute and Chronic Deficits in the Urinary Bladder after Spinal Contusion Injury in the Adult Rat

Juan J. Herrera et al.

JOURNAL OF NEUROTRAUMA (2010)

Review Immunology

B cells and autoantibodies: complex roles in CNS injury

Daniel P. Ankeny et al.

TRENDS IN IMMUNOLOGY (2010)

Editorial Material Medicine, Research & Experimental

Pathogenic antibodies are active participants in spinal cord injury

Gregory A. Dekaban et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Medicine, Research & Experimental

B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice

Daniel P. Ankeny et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Critical Care Medicine

FTY720 Reduces Inflammation and Promotes Functional Recovery after Spinal Cord Injury

Kangmin D. Lee et al.

JOURNAL OF NEUROTRAUMA (2009)

Article Clinical Neurology

The cellular inflammatory response in human spinal cords after injury

Jennifer C. Fleming et al.

BRAIN (2006)

Review Immunology

B-lymphocytes, innate immunity, and autoimmunity

M Viau et al.

CLINICAL IMMUNOLOGY (2005)

Article Neurosciences

Reactive astrocytes protect tissue and preserve function after spinal cord injury

JR Faulkner et al.

JOURNAL OF NEUROSCIENCE (2004)

Article Critical Care Medicine

Experimental modeling of spinal cord injury: Characterization of a force-defined injury device

SW Scheff et al.

JOURNAL OF NEUROTRAUMA (2003)